论文部分内容阅读
随机将经头颅ＣＴ证实的９６例急性脑梗塞患者分成治疗组与对照组，其年龄、性别、致病危险因素及病情均无明显差异。两组都给予低分子右旋糖酐加丹参及脑细胞活化剂脑活素、胞二磷胆碱治疗，治疗组同时联用尼莫通，用法为每日１次输注尼莫通输液（１０ｍｇ／５０ｍｌ酒精溶媒）治疗７天，此后给予尼莫通片剂９０ｍｇ／日，分３次口服。治疗１个月后观察疗效，按治疗前后神经功能缺损积分减少值统计处理，结果治疗组明显优于对照组，且血液流变学的改善亦较对照组明显。说明尼莫通对改善急性脑梗塞患者的症状及神经功能缺损方面有很高的疗效，同时能有效地改善血液粘稠度
96 cases of acute cerebral infarction confirmed by skull CT were randomly divided into treatment group and control group. There were no significant differences in age, sex, risk factors and condition between the two groups. Both groups were given low molecular weight dextran plus salvia miltiorrhiza and brain cell activator cerebrolysin, citicoline treatment, the treatment group also combined with nimotop daily usage of nimotone infusion (10mg / 50ml Alcohol vehicle) for 7 days, after which nimotop tablet 90mg / day, 3 times orally. After 1 month of treatment, the curative effect was observed. According to the statistics of neurologic deficit reduction before and after treatment, the treatment group was significantly better than the control group, and the improvement of hemorheology was also more obvious than that of the control group. Description of nimotop for improving symptoms and neurological deficits in patients with acute cerebral infarction has a high effect, while effectively improving blood viscosity